Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2017-06-22 2017-03-22
Drug Identification Number 02410419 02410419
Brand name IRINOTECAN IRINOTECAN
Common or Proper name IRINOTECAN IRINOTECAN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients IRINOTECAN HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 x 5mL EACH / CHAQUE
ATC code L01XX L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-03-22 2017-03-22
Estimated end date 2017-06-21 2017-06-09
Actual end date 2017-06-21
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Resolved June 21, 2017
Health Canada comments